van Varsseveld Otis C, Pijpers Adinda G H, Imren Ceren, Derikx Joep P M, van den Akker Chris H P, van Schuppen Joost, Keyzer-Dekker Claudia M G, Vermeulen Marijn J, Schurink Maarten, Lindeboom Maud Y A, Kooi Elisabeth M W, Hulscher Jan B F
Department of Surgery, Division of Pediatric Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Department of Pediatric Surgery, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam and Vrije Universiteit, Amsterdam, the Netherlands.
BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf060.
In infants born at < 26 weeks of gestational age (wGA) who develop necrotizing enterocolitis (NEC), medical and ethical considerations about whether surgery is the optimal treatment are complicated by a lack of group-specific outcome data. This study investigated nationwide 30-day mortality, surgical complications, and preoperative mortality risk factors in infants born at < 26 wGA who underwent surgery during the active phase of NEC.
This retrospective nationwide multicentre study included all infants born at < 26 wGA undergoing surgery for Bell's stage II/III NEC in the Netherlands between 2008 and 2022, regardless of outcome. Severe NEC was defined as Bell's stage III (confirmed by laparotomy and/or leading to death). The primary outcome was postoperative 30-day mortality. The incidence of major postoperative complications (Clavien-Madadi III-IV) was determined after excluding infants undergoing open-close procedures for massive bowel necrosis. Potential risk factors for death after surgery were assessed using multivariable logistic regression.
Of 288 infants with NEC Bell's stage ≥ II, 80 (27.8%) survived without surgery, 66 (22.9%) died before laparotomy, and 142 (49.3%) underwent laparotomy. In 142 surgically treated infants with severe NEC (57.0% male), the median gestational age was 25 + 0 (range 23 + 6 to 25 + 6) weeks + days, the median birthweight was 750 (range 485-1070) g, and the median age at surgery was 14 (range 2-66) days. Primary open-close surgery was performed in 34 of 142 infants (23.9%). In the remaining 108 infants, surgical management included stoma creation (63.0%), primary anastomosis (27.8%), or both (9.3%). Overall, the 30-day mortality rate among 142 infants was 47.2% (67 deaths). Death occurred after a primary or second-look open-close procedure in 37 infants, after multiorgan failure in 17, and from other causes in the remaining 13. After excluding 37 infants who died after open-close procedures, 30-day complications occurred in 23 (21.9%) of 105 surgically treated infants. There were 29 events in total, including reoperation for bowel perforation (5, 17%) or anastomotic leak/stenosis (5, 17%). Regression analysis identified no risk factors for 30-day mortality.
The 30-day mortality rate was 47.2% in infants born at < 26 wGA undergoing NEC surgery, most of whom died after an open-close procedure. Another 21.9% of infants experienced major complications.
在孕龄小于26周(wGA)的婴儿发生坏死性小肠结肠炎(NEC)时,由于缺乏特定分组的结局数据,关于手术是否为最佳治疗方法的医学和伦理考量变得复杂。本研究调查了在荷兰全国范围内,孕龄小于26周且在NEC活动期接受手术的婴儿的30天死亡率、手术并发症及术前死亡风险因素。
这项回顾性全国多中心研究纳入了2008年至2022年间在荷兰所有孕龄小于26周且因贝尔氏II/III期NEC接受手术的婴儿,无论结局如何。严重NEC定义为贝尔氏III期(经剖腹探查确认和/或导致死亡)。主要结局为术后30天死亡率。在排除因广泛性肠坏死进行肠造口关闭手术的婴儿后,确定主要术后并发症(Clavien-Madadi III-IV级)的发生率。使用多变量逻辑回归评估术后死亡的潜在风险因素。
在288例NEC贝尔氏分期≥II期的婴儿中,80例(27.8%)未经手术存活,66例(22.9%)在剖腹探查前死亡,142例(49.3%)接受了剖腹探查。在142例接受手术治疗的严重NEC婴儿中(57.0%为男性),中位孕龄为25 + 0(范围23 + 6至25 + 6)周 + 天,中位出生体重为750(范围485 - 1070)g,手术时的中位年龄为14(范围2 - 66)天。142例婴儿中有34例(23.9%)进行了初次肠造口关闭手术。在其余108例婴儿中,手术处理包括造口术(63.0%)、初次吻合术(27.8%)或两者皆有(9.3%)。总体而言,142例婴儿的30天死亡率为47.2%(67例死亡)。37例婴儿在初次或二次肠造口关闭手术后死亡,17例死于多器官功能衰竭,其余13例死于其他原因。在排除37例肠造口关闭手术后死亡的婴儿后,105例接受手术治疗的婴儿中有23例(21.9%)发生了30天并发症。总共发生了29起事件,包括因肠穿孔再次手术(5例,17%)或吻合口漏/狭窄(5例,17%)。回归分析未发现30天死亡率相关风险因素。
孕龄小于26周且接受NEC手术的婴儿30天死亡率为47.2%,其中大多数在肠造口关闭手术后死亡。另有21.9%的婴儿发生了主要并发症。